In an interview with the Beyond Biotech podcast, Martin Beck (Senior Vice President and Head of the Inflammation BU at Boehringer Ingelheim) spoke about the partnership with Brainomix and the potential for e-Lung to fast-track diagnosis of progressive pulmonary fibrosis. The episode covers the strategic rationale and clinical promise of pairing pharma with AI imaging.